The Centers for Disease Control and Prevention has quietly shut down a key team that focused on developing birth control guidance for women with chronic health conditions, such as sickle cell disease, heart disorders, and those at higher risk of HIV. The group of experts, consisting of about eight members, had played a crucial role in providing evidence-based recommendations to help healthcare providers safely prescribe contraceptives to women with complex medical needs.
This change has sparked concern among health professionals and advocacy groups, who warn that it could significantly impact Black women, particularly those living with sickle cell disease—a population already facing disproportionately high maternal health risks. Experts note that without these tailored guidelines, many women may face increased health complications due to limited access to safe and effective contraceptive options suited to their conditions.
Dr. Lee Warner, a former leader in the CDC’s reproductive health division, emphasized the importance of the group’s work, noting that it was the only federally backed source of birth control guidance specifically for women with chronic illnesses. Critics of the decision say the agency’s move eliminates a trusted resource for doctors treating high-risk patients.
The Department of Health and Human Services has described the move as part of a broader consolidation effort, aiming to streamline more than 40 maternal health programs. However, many health advocates argue that this consolidation sacrifices essential expertise and leaves a gap in care for some of the country’s most vulnerable women.
